Journal of Traditional Chinese Medicine ›› 2025, Vol. 45 ›› Issue (6): 1385-1394.DOI: 10.19852/j.cnki.jtcm.2025.06.016
• Original Articles • Previous Articles Next Articles
ZHANG Mingcai1, LIN Xun5, DU Guoqing1, LIU Congying2, YUAN Weian1, LI Wei3, YANG Jiayu4, CHEN Bo1, YU Xiaoyue3, XIONG Yizhe1, JIANG Enyu4, GAO Ningyang1, JIANG Sumin3, XU Zhenqiu1, WANG Xiang1, ZHAN Hongsheng1(
), WU Yufeng6(
)
Received:2024-02-27
Accepted:2025-01-18
Online:2025-12-15
Published:2025-11-24
Contact:
Prof. WU Yufeng, Traumatology & Orthopedics Department of Zhongshan Hospital Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan 528401, China. wyfdoc301@163.com, Telephone: +86-21-20256519; +86-760-88803661;About author:ZHANG Mingcai and LIN Xun are co-first authors and contributed equally to this work
Supported by:ZHANG Mingcai, LIN Xun, DU Guoqing, LIU Congying, YUAN Weian, LI Wei, YANG Jiayu, CHEN Bo, YU Xiaoyue, XIONG Yizhe, JIANG Enyu, GAO Ningyang, JIANG Sumin, XU Zhenqiu, WANG Xiang, ZHAN Hongsheng, WU Yufeng. Efficacy and safety of Shi’s cervical manipulation versus diclofenac for patients with acute and subacute neck pain: a multicenter clinical randomized trial[J]. Journal of Traditional Chinese Medicine, 2025, 45(6): 1385-1394.
| Characteristic | Trial group | Control group | P value |
|---|---|---|---|
| Participants (n) | 120 | 120 | - |
| Age (years, | 43.53±10.28 | 42.10±8.75 | 0.25 |
| Women (%) | 49.17 | 50.83 | 0.80 |
| Man (%) | 50.83 | 49.17 | |
| Mean BMI (kg/m2, | 23.45±2.60 | 24.09±2.77 | 0.07 |
| Mean duration of neck pain (weeks, | 6.26±2.80 | 5.96±2.68 | 0.40 |
| Baseline neck pain intensity on NRS | 0.68±0.22 | 0.72±0.22 | 0.10 |
| Baseline cervical dysfunction on NDI | 6.04±1.58 | 6.25±1.68 | 0.32 |
Table 1 Baseline demographic and clinical characteristics
| Characteristic | Trial group | Control group | P value |
|---|---|---|---|
| Participants (n) | 120 | 120 | - |
| Age (years, | 43.53±10.28 | 42.10±8.75 | 0.25 |
| Women (%) | 49.17 | 50.83 | 0.80 |
| Man (%) | 50.83 | 49.17 | |
| Mean BMI (kg/m2, | 23.45±2.60 | 24.09±2.77 | 0.07 |
| Mean duration of neck pain (weeks, | 6.26±2.80 | 5.96±2.68 | 0.40 |
| Baseline neck pain intensity on NRS | 0.68±0.22 | 0.72±0.22 | 0.10 |
| Baseline cervical dysfunction on NDI | 6.04±1.58 | 6.25±1.68 | 0.32 |
| Visit | Group | Mean difference ±SE | Confidence level of mean difference | Equivalence test | ||||
|---|---|---|---|---|---|---|---|---|
| 95% LCI | 95% UCI | t value | Freedom | P value | ||||
| Baseline | TG (n = 120) | 6.04±1.58 | -0.62 | 0.21 | 0.99 | 238 | 0.32 | |
| CG (n = 120) | 6.25±1.68 | |||||||
| Immediate after intervention | TG (n = 120) | 3.55±1.41 | -3.00 | -2.18 | -12.44 | 225.69 | 0.00 | |
| CG (n = 120) | 6.14±1.79 | |||||||
| Day 3 | TG (n = 120) | 2.59±1.60 | -2.65 | -1.57 | -7.75 | 201.25 | 0.00 | |
| CG (n = 120) | 4.70±2.52 | |||||||
| Week 1 | TG (n = 120) | 2.42±1.63 | -0.75 | 0.15 | -1.32 | 238 | 0.19 | |
| CG (n = 120) | 2.72±1.87 | |||||||
| Week 2 | TG (n = 120) | 1.89±1.43 | -0.68 | 0.11 | -1.42 | 238 | 0.16 | |
| CG (n = 120) | 2.18±1.66 | |||||||
| Week 4 | TG (n = 120) | 1.29±1.10 | -0.60 | -0.02 | -1.86 | 230.75 | 0.06 | |
| CG (n = 120) | 1.58±1.32 | |||||||
| Week 6 | TG (n = 120) | 1.02±1.08 | -0.53 | 0.04 | -1.67 | 235.16 | 0.10 | |
| CG (n = 119) | 1.26±1.58 | |||||||
| Week 8 | TG (n = 120) | 0.69±1.03 | -0.46 | 0.03 | -1.71 | 236 | 0.09 | |
| CG (n = 118) | 0.91±0.92 | |||||||
| Week 12 | TG (n = 119) | 0.42±0.75 | -0.34 | 0.04 | -1.59 | 234 | 0.11 | |
| CG (n = 117) | 0.57±0.72 | |||||||
| Week 26 | TG (n = 114) | 0.16±0.45 | -0.71 | -0.29 | -4.73 | 150.01 | 0.00 | |
| CG (n = 110) | 0.66±1.03 | |||||||
| Week 52 | TG (n = 105) | 0.09±0.33 | -0.65 | -0.25 | -4.41 | 120.94 | 0.00 | |
| CG (n = 100) | 0.55±0.98 | |||||||
Table 2 Comparative statistical results between two groups of NRS
| Visit | Group | Mean difference ±SE | Confidence level of mean difference | Equivalence test | ||||
|---|---|---|---|---|---|---|---|---|
| 95% LCI | 95% UCI | t value | Freedom | P value | ||||
| Baseline | TG (n = 120) | 6.04±1.58 | -0.62 | 0.21 | 0.99 | 238 | 0.32 | |
| CG (n = 120) | 6.25±1.68 | |||||||
| Immediate after intervention | TG (n = 120) | 3.55±1.41 | -3.00 | -2.18 | -12.44 | 225.69 | 0.00 | |
| CG (n = 120) | 6.14±1.79 | |||||||
| Day 3 | TG (n = 120) | 2.59±1.60 | -2.65 | -1.57 | -7.75 | 201.25 | 0.00 | |
| CG (n = 120) | 4.70±2.52 | |||||||
| Week 1 | TG (n = 120) | 2.42±1.63 | -0.75 | 0.15 | -1.32 | 238 | 0.19 | |
| CG (n = 120) | 2.72±1.87 | |||||||
| Week 2 | TG (n = 120) | 1.89±1.43 | -0.68 | 0.11 | -1.42 | 238 | 0.16 | |
| CG (n = 120) | 2.18±1.66 | |||||||
| Week 4 | TG (n = 120) | 1.29±1.10 | -0.60 | -0.02 | -1.86 | 230.75 | 0.06 | |
| CG (n = 120) | 1.58±1.32 | |||||||
| Week 6 | TG (n = 120) | 1.02±1.08 | -0.53 | 0.04 | -1.67 | 235.16 | 0.10 | |
| CG (n = 119) | 1.26±1.58 | |||||||
| Week 8 | TG (n = 120) | 0.69±1.03 | -0.46 | 0.03 | -1.71 | 236 | 0.09 | |
| CG (n = 118) | 0.91±0.92 | |||||||
| Week 12 | TG (n = 119) | 0.42±0.75 | -0.34 | 0.04 | -1.59 | 234 | 0.11 | |
| CG (n = 117) | 0.57±0.72 | |||||||
| Week 26 | TG (n = 114) | 0.16±0.45 | -0.71 | -0.29 | -4.73 | 150.01 | 0.00 | |
| CG (n = 110) | 0.66±1.03 | |||||||
| Week 52 | TG (n = 105) | 0.09±0.33 | -0.65 | -0.25 | -4.41 | 120.94 | 0.00 | |
| CG (n = 100) | 0.55±0.98 | |||||||
| Visit | Group | Mean difference ± SE | Confidence level of mean difference | Equivalence test | ||||
|---|---|---|---|---|---|---|---|---|
| 95% LCI | 95% UCI | t value | Freedom | P value | ||||
| Baseline | TG (n = 120) | 0.676±0.216 | -0.10 | 0.01 | -1.66 | 238 | 0.10 | |
| CG (n = 120) | 0.724±0.224 | |||||||
| Immediate after intervention | TG (n = 120) | 0.412±0.159 | -0.33 | -0.22 | -9.49 | 191.80 | 0.00 | |
| CG (n = 120) | 0.685±0.272 | |||||||
| Day 3 | TG (n = 120) | 0.231±0.127 | -0.41 | -0.31 | -13.15 | 168.99 | 0.00 | |
| CG (n = 120) | 0.590±0.271 | |||||||
| Week 1 | TG (n = 120) | 0.181±0.111 | -0.44 | -0.34 | -14.92 | 160.86 | 0.00 | |
| CG (n = 120) | 0.567±0.261 | |||||||
| Week 2 | TG (n = 120) | 0.120±0.094 | -0.43 | -0.33 | -15.29 | 151.45 | 0.00 | |
| CG (n = 120) | 0.496±0.252 | |||||||
| Week 4 | TG (n = 120) | 0.070±0.073 | -0.80 | -0.12 | -2.64 | 214.81 | 0.00 | |
| CG (n = 120) | 0.458±0.240 | |||||||
| Week 6 | TG (n = 120) | 0.039±0.055 | -0.42 | -0.33 | -16.45 | 130.06 | 0.00 | |
| CG (n = 119) | 0.411±0.241 | |||||||
| Week 8 | TG (n = 120) | 0.021±0.037 | -0.37 | -0.29 | -16.53 | 123.85 | 0.00 | |
| CG (n = 118) | 0.349±0.213 | |||||||
| Week 12 | TG (n = 119) | 0.013±0.036 | -0.30 | -0.23 | -14.55 | 123.93 | 0.00 | |
| CG (n = 117) | 0.279±0.195 | |||||||
| Week 26 | TG (n = 114) | 0.008±0.027 | -0.25 | -0.18 | -12.17 | 114.54 | 0.00 | |
| CG (n = 110) | 0.221±0.182 | |||||||
| Week 52 | TG (n = 105) | 0.005±0.017 | -0.21 | -0.14 | -9.97 | 101.73 | 0.00 | |
| CG (n = 100) | 0.179±0.175 | |||||||
Table 3 Comparative statistical results between two groups of NDI
| Visit | Group | Mean difference ± SE | Confidence level of mean difference | Equivalence test | ||||
|---|---|---|---|---|---|---|---|---|
| 95% LCI | 95% UCI | t value | Freedom | P value | ||||
| Baseline | TG (n = 120) | 0.676±0.216 | -0.10 | 0.01 | -1.66 | 238 | 0.10 | |
| CG (n = 120) | 0.724±0.224 | |||||||
| Immediate after intervention | TG (n = 120) | 0.412±0.159 | -0.33 | -0.22 | -9.49 | 191.80 | 0.00 | |
| CG (n = 120) | 0.685±0.272 | |||||||
| Day 3 | TG (n = 120) | 0.231±0.127 | -0.41 | -0.31 | -13.15 | 168.99 | 0.00 | |
| CG (n = 120) | 0.590±0.271 | |||||||
| Week 1 | TG (n = 120) | 0.181±0.111 | -0.44 | -0.34 | -14.92 | 160.86 | 0.00 | |
| CG (n = 120) | 0.567±0.261 | |||||||
| Week 2 | TG (n = 120) | 0.120±0.094 | -0.43 | -0.33 | -15.29 | 151.45 | 0.00 | |
| CG (n = 120) | 0.496±0.252 | |||||||
| Week 4 | TG (n = 120) | 0.070±0.073 | -0.80 | -0.12 | -2.64 | 214.81 | 0.00 | |
| CG (n = 120) | 0.458±0.240 | |||||||
| Week 6 | TG (n = 120) | 0.039±0.055 | -0.42 | -0.33 | -16.45 | 130.06 | 0.00 | |
| CG (n = 119) | 0.411±0.241 | |||||||
| Week 8 | TG (n = 120) | 0.021±0.037 | -0.37 | -0.29 | -16.53 | 123.85 | 0.00 | |
| CG (n = 118) | 0.349±0.213 | |||||||
| Week 12 | TG (n = 119) | 0.013±0.036 | -0.30 | -0.23 | -14.55 | 123.93 | 0.00 | |
| CG (n = 117) | 0.279±0.195 | |||||||
| Week 26 | TG (n = 114) | 0.008±0.027 | -0.25 | -0.18 | -12.17 | 114.54 | 0.00 | |
| CG (n = 110) | 0.221±0.182 | |||||||
| Week 52 | TG (n = 105) | 0.005±0.017 | -0.21 | -0.14 | -9.97 | 101.73 | 0.00 | |
| CG (n = 100) | 0.179±0.175 | |||||||
| Visit | Flexion-extension ROM | Lateral-bending ROM | Axial-rotation ROM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TG | CG | P value | TG | CG | P value | TG | CG | P value | ||||
| Baseline | 81±8 | 79±8 | 0.10 | 82±8 | 80±7 | 0.12 | 103±45 | 102±8 | 0.17 | |||
| Immediate after intervention | 84±7 | 80±7 | 0.00 | 87±6 | 81±7 | 0.00 | 115±7 | 104±8 | 0.00 | |||
| Day 3 | 86±9 | 82±6 | 0.00 | 88±5 | 83±6 | 0.00 | 120±7 | 115±10. | 0.00 | |||
| Week 1 | 90±5 | 85±5 | 0.00 | 91±6 | 86±5 | 0.00 | 126±7 | 115±11 | 0.00 | |||
| Week 2 | 93±6 | 87±5 | 0.00 | 95±7 | 89±5 | 0.00 | 129±9 | 126±12 | 0.00 | |||
| Week 4 | 94±7 | 89±5 | 0.00 | 96±8 | 89±5 | 0.00 | 131±8 | 128±11 | 0.02 | |||
| Week 6 | 94±7 | 90±5 | 0.00 | 96±8 | 90±6 | 0.00 | 132±8 | 129±9 | 0.03 | |||
| Week 8 | 95±7 | 93±5 | 0.11 | 96±8 | 94±5 | 0.00 | 132±8 | 130±9 | 0.04 | |||
| Week 12 | 95±6 | 95±5 | 0.87 | 97±8 | 96±6 | 0.17 | 133±7 | 132±8 | 0.08 | |||
| Week 26 | 96±6 | 96±5 | 0.84 | 98±8 | 97±6 | 0.14 | 134±7 | 132±7 | 0.14 | |||
| Week 52 | 100±6 | 99±6 | 0.11 | 101±7 | 99±6 | 0.02 | 135±5 | 134±5 | 0.15 | |||
Table 4 Comparative statistical results between two groups of ROM (°)
| Visit | Flexion-extension ROM | Lateral-bending ROM | Axial-rotation ROM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TG | CG | P value | TG | CG | P value | TG | CG | P value | ||||
| Baseline | 81±8 | 79±8 | 0.10 | 82±8 | 80±7 | 0.12 | 103±45 | 102±8 | 0.17 | |||
| Immediate after intervention | 84±7 | 80±7 | 0.00 | 87±6 | 81±7 | 0.00 | 115±7 | 104±8 | 0.00 | |||
| Day 3 | 86±9 | 82±6 | 0.00 | 88±5 | 83±6 | 0.00 | 120±7 | 115±10. | 0.00 | |||
| Week 1 | 90±5 | 85±5 | 0.00 | 91±6 | 86±5 | 0.00 | 126±7 | 115±11 | 0.00 | |||
| Week 2 | 93±6 | 87±5 | 0.00 | 95±7 | 89±5 | 0.00 | 129±9 | 126±12 | 0.00 | |||
| Week 4 | 94±7 | 89±5 | 0.00 | 96±8 | 89±5 | 0.00 | 131±8 | 128±11 | 0.02 | |||
| Week 6 | 94±7 | 90±5 | 0.00 | 96±8 | 90±6 | 0.00 | 132±8 | 129±9 | 0.03 | |||
| Week 8 | 95±7 | 93±5 | 0.11 | 96±8 | 94±5 | 0.00 | 132±8 | 130±9 | 0.04 | |||
| Week 12 | 95±6 | 95±5 | 0.87 | 97±8 | 96±6 | 0.17 | 133±7 | 132±8 | 0.08 | |||
| Week 26 | 96±6 | 96±5 | 0.84 | 98±8 | 97±6 | 0.14 | 134±7 | 132±7 | 0.14 | |||
| Week 52 | 100±6 | 99±6 | 0.11 | 101±7 | 99±6 | 0.02 | 135±5 | 134±5 | 0.15 | |||
| 1. |
Kazeminasab S, Nejadghaderi SA, Amiri P, et al. Neck pain: global epidemiology, trends and risk factors. BMC Musculoskeletal Disorders 2022; 23: 26.
DOI PMID |
| 2. | Safri S, Kolahi AA, Hoy D, et al. Global, regional, and national burden of neck pain in the general population, 1990-2017: systematic analysis of the Global Burden of Disease Study 2017. BMJ 2020; 26: 368. |
| 3. | Cohen SP, Hooten WM. Advances in the diagnosis and management of neck pain. BMJ 2017; 358: j3221. |
| 4. |
Hage R, Detrembleur C, Dierick F, Brismée JM, Roussel N, Pitance L. Sensorimotor performance in acute subacute non-specifc neck pain: a nonrandomized prospective clinical trial with intervention. BMC Musculoskeletal Disorders 2021; 22: 1017.
DOI |
| 5. |
Côté P, van der Velde G, Cassidy JD, et al. The burden and determinants of neck pain in workers: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976) 2008; 33: S60-74.
DOI URL |
| 6. |
Côté P, Kristman V, Vidmar M, et al. The prevalence and incidence of work absenteeism involving neck pain: a cohort of Ontario lost-time claimants. Spine (Phila Pa 1976) 2008; 33: S192-8.
DOI URL |
| 7. | Childs JD, Cleland JA, Elliott JM, et al. Neck pain: clinical practice guidelines linked to the international classifcation of functioning, disability, and health from the Orthopedic Section of the American Physical Therapy Association. J Orthop Sports Phys Ther 2008; 38: A1-34. |
| 8. |
Vos T, Barber RM, Bell B, et al. Global, regional, and national incidence, prevalence,and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 743-800.
DOI URL |
| 9. |
Oscar J, Pico-Espinosa MSc, Pierre Côté, et al. Trajectories of Pain Intensity Over 1 Year in Adults With Disabling Subacute or Chronic Neck Pain. Clin J Pain 2019; 35: 678-85.
DOI URL |
| 10. |
Bronfort G, Evans R, Anderson AV, Svendsen KH, Bracha Y, Grimm RH. Spinal manipulation, medication, or home exercise with advice for acute and subacute neck pain: a randomized trial. Ann Intern Med 2012; 156: 1-10.
DOI PMID |
| 11. | Wang H, Jiang E, Wang K, et al. Shi’s Daoyin therapy for neck pain: a randomized controlled trial. Evid Based Complementary Alternat Med 2018; 12: 4983891. |
| 12. |
Lauche R, Stumpe C, Fehr J, et al. The effects of Tai Chi and neck exercises in the treatment of chronic nonspecific neck pain: a randomized controlled trial. J Pain 2016; 17: 1013-27.
DOI URL |
| 13. |
Wang H, Wang K, Deng Z, et al. Effects of facet joint degeneration on stress alterations in cervical spine C5-C6: a finite element analysis. Math Biosci Eng 2019; 16: 7447-57.
DOI PMID |
| 14. |
Zhang MC, Du GQ, Liu CY, et al. Efficacy and safety of Shi-style cervical manipulation therapy for treating acute and subacute neck pain: study protocol for a randomized controlled trial. Trials 2021; 22: 123.
DOI PMID |
| 15. |
Spitzer WO, Skovron ML, Salmi LR, et al. Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining “whiplash” and its management. Spine (Phila Pa 1976) 1995; 20: 1S-73S.
DOI URL |
| 16. |
Guzman J, Hurwitz EL, Carroll LJ, et al. Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. A new conceptual model of neck pain: linking onset, course, and care: the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine 2008; 33: S14-23.
DOI URL |
| 17. |
Robert WH, Meredith CB, Meredith B, et al. Consensus practice guidelines on interventions for cervical spine (facet) joint pain from a multispecialty international working group. Reg Anesth Pain Med 2022; 47: 3-59.
DOI URL |
| 18. |
Toci GR, Canseco JA, Karamian BA, et al. The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy. J Craniovertebr Junction Spine 2022; 13: 94-100.
DOI PMID |
| 19. | Zheng S, Wu YX, Wang JY, et al. Identifying the characteristics of patients with cervical degenerative disease for surgical treatment from 17-year real-world data: retrospective study. JMIR Med Inform 2020; 8: e16076. |
| 20. |
Kadaňka Z, Bednařík J, Novotný O, Urbánek I, Dušek L. Cervical spondylotic myelopathy: conservative versus surgical treatment after 10 years. Eur Spine J 2011; 20: 1533-8.
DOI PMID |
| 21. | Veeravagu A, Connolly ID, Lamsam L, et al. Surgical outcomes of cervical spondylotic myelopathy: an analysis of a national, administrative, longitudinal database. Neurosurg Focus 2016; 40: E11. |
| 22. | Perrot S, Cohen M, Barke A, et al. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain 2019; 160: 77-82. |
| 23. |
Qaseem A, Wilt TJ, McLean RM, Forciea MA. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017; 166: 514-30.
DOI PMID |
| 24. | Parreira ps, Maher CG, Ferreira ML. Effect of education on non-specific neck and low back pain: a Meta-analysis of randomized controlled trials. Man Ther 2016; 23: e3-4. |
| 25. | Pereira M, Comans T, Sjogaard G, et al. The impact of workplace ergonomics and neck-specific exercise versus ergonomics and health promotion interventions on office worker productivity: a cluster-randomized trial. Scand J Work Environ Health 2019; 45: 42-52. |
| 26. |
Cleland JA, Glynn P, Whitman JM, Eberhart SL, MacDonald C, Childs JD. Short-term effects of thrust versus nonthrust mobilization/manipulation directed at the thoracic spine in patients with neck pain: a randomized clinical trial. Phys Ther 2007; 87: 431-40.
DOI PMID |
| 27. |
Choudhry NK, Sheila Fifer, Fontanet CP, et al. Effect of a biopsychosocial intervention or postural therapy on disability and health care spending among patients with acute and subacute spine pain: the SPINE CARE randomized clinical trial. JAMA 2022; 328: 2334-44.
DOI PMID |
| 28. | Lee NW, Kim GH, Heo I, et al. Chuna (or Tuina) manual therapy for musculoskeletal disorders: a systematic review and Meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2017; 26: 8218139. |
| 29. |
Van Dongen JM, Groeneweg R, Rubinstein SM, et al. Cost-effectiveness of manual therapy versus physiotherapy in patients with sub-acute and chronic neck pain: a randomised controlled trial. Eur Spine J 2016; 25: 2087-96.
DOI PMID |
| 30. | Lee J, Cho JH, Kim KW, et al. Chuna manual therapy vs usual care for patients with nonspecific chronic neck pain. JAMA Network Open 2021; 4: e2113757. |
| 31. |
Wang C, Schmid CH, Rones R, et al. A randomized trial of Tai Chi for fibromyalgia. N Eng J Med 2010; 363: 743-54.
DOI URL |
| 32. |
Wang C, Schmid CH, Iversen MD, et al. Comparative effectiveness of Tai Chi versus physical therapy for knee osteoarthritis: a randomized trial. Ann Intern Med 2016; 165: 77-86.
DOI PMID |
| 33. |
Nielsen A, Dusek JA, Lsia TS, Trick H. Acupuncture therapy as an evidence-based nonpharmacologic strategy for comprehensive acute pain care: the academic consortium pain task force white paper update. Pain Med 2022; 23: 1582-612.
DOI PMID |
| 34. | Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture trialists' collaboration. acupuncture for chronic pain: update of an individual patient data Meta-analysis. J Pain 2018; 19: 455-74. |
| 35. | Witt CM, Vertosick EA, Foster NE, et al. The effect of patient characteristics on acupuncture treatment outcomes: An individual patient data Meta-analysis of 20 827 chronic pain patients in randomized controlled trials Clin J Pain 2019; 35: 428-34. |
| 36. | Kim H, Mawla I, Lee J, et al. Reduced tactile acuity in chronic low back pain is linked with structural neuroplasticity in primary somatosensory cortex and is modulated by acupuncture therapy. Neuro Image 2020; 217: 116899. |
| 37. |
Wang L, Yin Z, Zhang Y, et al. Optimal acupuncture methods for nonspecific low back pain: a systematic review and bayesian network Meta-analysis of randomized controlled trials. J Pain Res 2021; 14: 1097-1112.
DOI PMID |
| 38. |
Paige NM, Miake-Lye IM, Booth MS, et al. Association of spinal manipulative therapy with clinical benefit and harm for acute low back pain: systematic review and Meta-analysis. JAMA 2017; 317: 1451-60.
DOI PMID |
| 39. | Coulter ID, Crawford C, Vernon H, et al. Manipulation and mobilization for treating chronic nonspecific neck pain: a systematic review and Meta-analysis for an appropriateness panel. Pain Physician 2019; 22: E55-70. |
| 40. |
Zaproudina N, Hänninen OO, Airaksinen O. Effectiveness of traditional bone setting in chronic neck pain: randomized clinical trial. J Manip Physiol Ther 2007; 30: 432-7.
DOI PMID |
| 41. |
Carlos BU, Juan Jose GG, Ernesto AL, et al. Manual therapy versus therapeutic exercise in non-specific chronic neck pain: a randomized controlled trial. Trials 2020; 21: 682.
DOI |
| [1] | WAN Le, JIANG Weiyu, ZHANG Wenchun, Yingsin Peng, LIU Jiancheng. Effects of 4 kinds of Chinese traditional Qigong exercises on cervical spondylosis: a network Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2025, 45(6): 1191-1200. |
| [2] | HAO Shulan, NAN Peng, LIU Likun, LI Xiaoli, ZHONG Qiming, GAO Yu, WANG Xixing, NIE Yingfang. Effectiveness of Yiqi Chupi powder (益气除疲散) for alleviating cancer-related fatigue in patients following colorectal cancer surgery: a randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2025, 45(5): 1119-1126. |
| [3] | LI Shanyi, GAO Qi, LI Yanjie, ZHANG Yaling, CHEN Xiaoqi. Efficacy and safety of Yangxiao Fukang granule (养消复康颗粒) in the treatment of stage Ⅲ hepatitis B related liver cancer: study protocol for a randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2025, 45(5): 1127-1134. |
| [4] | LU Zhenkai, TAN Chang, ZHI Yingjie, ZHANG Xuming, XIE Yanming. Efficacy and safety of Compound E’jiao Jiang (复方阿胶浆) for treating leukopenia based: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2025, 45(5): 941-953. |
| [5] | ZHANG Hongchun, LIU Jian, CHEN Sheng, ZHANG Wei, LU Xuechao, LI Ying, YU Xueqing, HUANG Yan, SU Lianhua, WEI Baolin, LI Zhuyin, PEI Shuai, LEI Xiang, YANG Daowen, GUO Jianning. Efficacy and safety of Suhuang Zhike capsule (苏黄止咳胶囊) for cough variant asthma: a multicenter, single-arm, open-label phase IV real-world clinical trial [J]. Journal of Traditional Chinese Medicine, 2025, 45(4): 817-828. |
| [6] | XU Jian, LIU Yuntao, LUO Zhihao, ZHAO Zhen, WANG Dawei, LIU Qing. Chinese patent medicine for atherosclerosis: a systematic review and Meta-analysis of randomized controlled trials [J]. Journal of Traditional Chinese Medicine, 2024, 44(6): 1082-1090. |
| [7] | WU Qiaomin, GUAN Xuanke, LIU Jinfeng, WANG Yanli, CHANG Xing, LIU Zhiming, LIU Ruxiu. Compound Tongyang Fumai decoction (通阳复脉方) improves quality of life in sick sinus syndrome: a randomized controlled study [J]. Journal of Traditional Chinese Medicine, 2024, 44(6): 1247-1253. |
| [8] | ZHANG Meizhen, HAO Xiaohui, TANG Yiting, CHEN Yupeng, HE Puyu, ZHAO Liming, PANG Bing, NI Qing. Efficacy and safety of Buyang Huanwu decoction (补阳还五汤) for diabetic peripheral neuropathy: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2023, 43(5): 841-850. |
| [9] | SUN Wu, ZHAO Yuwei, LIAO Liang, ZHAO Zhonghui, CHEN Shiqi, YAN Xiaoling, WANG Xueyao, CHAO Guojun, ZHOU Jian. Effectiveness and safety of Xuebijing injection for patients with coronavirus disease 2019: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2023, 43(4): 631-639. |
| [10] | LUO Xin, XIE Jing, HUANG Li, GAN Wenfan, CHEN Ming. Efficacy and safety of activating blood circulation and removing blood stasis of Traditional Chinese Medicine for managing renal fibrosis in patients with chronic kidney disease: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2023, 43(3): 429-440. |
| [11] | ZHANG Yuehong, SHAO Xianzhi, ZHAO Qianlong, ZHAN Hualong, ZHANG Jianhua, DU Sisi, CHEN Jing, LIU Yingfang, ZHOU Haiwang, CHEN Xinsheng, HONG Ying, LIAN Fengmei, TONG Xiaolin, BA Yuanming. Effectiveness of Xiangsha Liujun pills (香砂六君丸) on decreased digestive function in convalescent patients of coronavirus disease 2019: a randomized, double blind, placebo controlled clinical trial [J]. Journal of Traditional Chinese Medicine, 2023, 43(3): 552-558. |
| [12] | ZHOU Yingyan, LIANG Huasheng, YAN Jingyao, HE Xiaohong, PAN Lili, LI Xue, CHEN Xianghong, CHEN Xiumin, YANG Aicheng, HUANG Qingchun. Effectiveness and safety of tripterygium glycosides tablet (雷公藤多苷片) for lupus nephritis: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2022, 42(5): 671-680. |
| [13] | LIN Yi, LI Xun, WANG Zi, ZHENG Xiaoran, HANG Haiyan, LI Lingling. Efficacy and safety of external application of Chinese herbal medicine for psoriasis vulgaris: a systematic review of randomized controlled trials [J]. Journal of Traditional Chinese Medicine, 2022, 42(4): 493-504. |
| [14] | HUANG Yusi, YANG Jiju, LI Xinyi, HAO Huifeng, LI Chong, ZHANG Fan, LIN Haiming, XIE Xianfei, HE Ke, TIAN Guihua. Effectiveness and safety of electroacupuncture for the treatment of pain after laparoscopic surgery: a systematic review [J]. Journal of Traditional Chinese Medicine, 2022, 42(4): 505-512. |
| [15] | LIU Ying, ZOU Wen, XIAN Qingfei, DENG Xin, ZHANG Fuchun, WANG Li, LI Yonghong, LUN Wenhui, WANG Jian. Efficacy and safety of Mianyi granules (+mianyi+) for reversal of immune nonresponse following antiretroviral therapy of human immunodeficiency virus-1: a randomized, double-blind, multi-center, placebo-controlled trial [J]. Journal of Traditional Chinese Medicine, 2022, 42(3): 432-438. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
Sponsored by China Association of Chinese Medicine
& China Academy of Chinese Medical Sciences
16 Nanxiaojie, Dongzhimen Nei, Beijing, China. 100700 Email: jtcmen@126.com
Copyright 2020 Journal of Traditional Chinese Medicine. All rights reserved.
